Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Edith Chan

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Biological Chemistry|December 19, 2015
Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple SclerosisJustin Warne, Gareth Pryce, Julia M Hill, et al.
ACS Pharmacology & Translational Science|November 20, 2025
Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced PainSara Hestehave, Silvia Dragoni, Philip Fallon, et al.
Brain : a Journal of Neurology|November 30, 2013
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosisSarah Al-Izki, Gareth Pryce, Deborah J R Hankey, et al.
Journal of Medicinal Chemistry|April 13, 2018
Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-CellsJonathan Powell, Filipa Mota, David Steadman, et al.
Nature Reviews. Drug Discovery|October 18, 2008
Genomic-scale prioritization of drug targets: the TDR Targets databaseFernán Agüero, Bissan Al-Lazikani, Martin Aslett, et al.
Nature|May 24, 2023
A small-molecule PI3Kα activator for cardioprotection and neuroregenerationGrace Q Gong, Benoit Bilanges, Ben Allsop, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Biological Chemistry|December 19, 2015
Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple SclerosisJustin Warne, Gareth Pryce, Julia M Hill, et al.
ACS Pharmacology & Translational Science|November 20, 2025
Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced PainSara Hestehave, Silvia Dragoni, Philip Fallon, et al.
Brain : a Journal of Neurology|November 30, 2013
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosisSarah Al-Izki, Gareth Pryce, Deborah J R Hankey, et al.
Journal of Medicinal Chemistry|April 13, 2018
Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-CellsJonathan Powell, Filipa Mota, David Steadman, et al.
Nature Reviews. Drug Discovery|October 18, 2008
Genomic-scale prioritization of drug targets: the TDR Targets databaseFernán Agüero, Bissan Al-Lazikani, Martin Aslett, et al.
Nature|May 24, 2023
A small-molecule PI3Kα activator for cardioprotection and neuroregenerationGrace Q Gong, Benoit Bilanges, Ben Allsop, et al.
Pageof 4